“…Several chemical inhibitors of antiapoptotic Bcl-2-family proteins based on mimicking BH3 peptides have been described (Wang et al, 2000a, b;Degterev et al, 2001;Enyedy et al, 2001;Tzung et al, 2001;Kutzki et al, 2002;Leone et al, 2003;Becattini et al, 2004;Pellecchia and Reed, 2004;Walensky et al, 2004;Oltersdorf et al, 2005;Mohan et al, 2007;Nguyen et al, 2007;Kitada et al, 2008), and at least three of these agents are currently being tested in human clinical trials for cancer (reviewed by Reed and Pellecchia, 2005). The structural basis for activation of Bax and Bak by BH3 peptides has not yet been reported.…”